Centene Corporation (CNC) EBITDA Margin: -2.64%
Is Centene Corporation’s EBITDA margin high or low?
Centene Corporation's EBITDA margin of -2.64% is 206% below its 5-year average of 2.49%, near the low end of its 5-year range (-2.64%–4.28%).
The EBITDA margin for Centene Corporation (CNC) is -2.64% as of Wednesday, June 10, 2026. It is below its 12-month average by 555.17% (0.58%).
CNC EBITDA Margin Chart
CNC Average EBITDA Margin Chart
CNC Current vs Average EBITDA Margin Chart
CNC EBITDA Margin Metrics
EBITDA MARGIN
-2.64%
EBITDA MARGIN AVG TTM
0.58%
EBITDA MARGIN AVG 3Y
1.90%
EBITDA MARGIN AVG 5Y
2.49%
EBITDA MARGIN AVG 10Y
3.08%
EBITDA MARGIN AVG 15Y
3.34%
EBITDA MARGIN AVG 20Y
3.57%
CURRENT VS TTM AVG
-555.17%
CURRENT VS 3Y AVG
-238.58%
CURRENT VS 5Y AVG
-206.10%
CURRENT VS 10Y AVG
-185.82%
CURRENT VS 15Y AVG
-179.06%
CURRENT VS 20Y AVG
-173.93%
CNC Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Centene Corporation (CNC) | — | -2.64% | 0.58% | 1.90% | 2.49% |
| IQVIA Holdings Inc. (IQV) | $30.60B | 21.24% | 21.82% | 21.39% | 20.63% |
| Zoetis Inc. (ZTS) | $34.20B | 42.98% | 42.41% | 42.38% | 41.76% |
| DexCom, Inc. (DXCM) | $29.24B | 24.96% | 24.20% | 23.29% | 21.36% |
| Biogen Inc. (BIIB) | $29.00B | 31.60% | 31.28% | 30.38% | 32.54% |
| Veeva Systems Inc. (VEEV) | $27.37B | 28.68% | 27.64% | 24.37% | 25.68% |
| Agilent Technologies, Inc. (A) | $38.26B | 26.41% | 27.60% | 26.98% | 26.47% |
| Waters Corporation (WAT) | $23.83B | 31.97% | 33.50% | 33.77% | 33.93% |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 30.67% | 31.14% | 31.31% | 30.59% |
| BioNTech SE (BNTX) | $21.81B | -9.29% | -11.31% | 22.27% | 24.39% |
Margin Comparison
Gross Margin
14.9%
EBITDA Margin
-2.6%
Operating Margin
-3.7%
Net Margin
-3.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
Centene Corporation EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Centene Corporation EBITDA Margin FAQ
- What is the EBITDA margin for Centene Corporation (CNC)?
- The EBITDA margin for CNC stock is -2.64%.
- Is Centene Corporation's EBITDA margin high or low?
- Centene Corporation's EBITDA margin of -2.64% is 206% below its 5-year average of 2.49%, near the low end of its 5-year range (-2.64%–4.28%).
- What is the TTM average EBITDA margin for Centene Corporation (CNC)?
- The TTM average EBITDA margin for CNC stock is 0.58%.
- What is the 3Y average EBITDA margin for Centene Corporation (CNC)?
- The 3Y average EBITDA margin for CNC stock is 1.90%.
- What is the 5Y average EBITDA margin for Centene Corporation (CNC)?
- The 5Y average EBITDA margin for CNC stock is 2.49%.
- What is the 10Y average EBITDA margin for Centene Corporation (CNC)?
- The 10Y average EBITDA margin for CNC stock is 3.08%.
- What is the 15Y average EBITDA margin for Centene Corporation (CNC)?
- The 15Y average EBITDA margin for CNC stock is 3.34%.
- What is the 20Y average EBITDA margin for Centene Corporation (CNC)?
- The 20Y average EBITDA margin for CNC stock is 3.57%.
Centene Corporation EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | -2.64% |
| 2024-12-31 | 3.80% |
| 2023-12-31 | 3.65% |
| 2022-12-31 | 2.81% |
| 2021-12-31 | 3.03% |
| 2020-12-31 | 4.28% |
| 2019-12-31 | 3.80% |
| 2018-12-31 | 3.67% |
| 2017-12-31 | 3.62% |
| 2016-12-31 | 4.08% |
| 2015-12-31 | 3.74% |
| 2014-12-31 | 3.51% |
| 2013-12-31 | 3.34% |
| 2012-12-31 | 2.58% |
| 2011-12-31 | 5.12% |
| 2010-12-31 | 5.04% |
| 2009-12-31 | 4.82% |
| 2008-12-31 | 5.61% |
| 2007-12-31 | 3.88% |
| 2006-12-31 | 0.42% |
| 2005-12-31 | 6.83% |
| 2004-12-31 | 8.09% |
| 2003-12-31 | 7.60% |
| 2002-12-31 | 9.48% |
| 2001-12-31 | 6.22% |
| 2000-12-31 | 3.41% |
| 1999-12-31 | -3.28% |
Related Metrics
About Centene Corporation
Centene Corporation functions as a diverse, multinational healthcare organization, primarily dedicated to delivering a comprehensive range of programs and services to underinsured and uninsured individuals throughout the United States. Its Managed Care division provides extensive health plan coverage for people enrolled in various government-sponsored initiatives. These initiatives include Medicaid, the State Children's Health Insurance Program (SCHIP), long-term services and support, foster care, and specialized Medicare-Medicaid plans that cater to individuals dually eligible for both programs, as well as aged, blind, or disabled populations. The broad spectrum of benefits within these health plans encompasses primary and specialty physician care, inpatient and outpatient hospital services, emergency and urgent care, prenatal support, laboratory and X-ray diagnostics, and home-based primary care. Complementary services feature transportation assistance, vision and dental care, telehealth access, immunizations, specialty pharmacy, therapy, social work, nurse advisory support, and care coordination. Additionally, members are covered for prescriptions, limited over-the-counter medications, medical equipment, and essential behavioral health and substance abuse services. This segment also extends its offerings to commercial healthcare products for individuals and employer groups of various sizes. Centene's Specialty Services segment delivers a distinct set of solutions, including pharmacy benefits management (PBM), 24/7 nurse advice lines and after-hours support, vision and dental services, and staffing provisions for correctional systems and other government agencies. This division also serves beneficiaries eligible for the Military Health System. Its clientele for these specialized services spans state programs, correctional institutions, healthcare organizations, employer groups, and other commercial entities. The company delivers its healthcare services through an expansive network comprising primary and specialty care physicians, hospitals, and various ancillary providers. Established in 1984, Centene Corporation is headquartered in St. Louis, Missouri.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Sarah London